PMID: 11901912Mar 21, 2002Paper

Therapy for stage IIIB and stage IV non-small cell lung cancer

Clinics in Chest Medicine
Tracy E Kim, John R Murren

Abstract

The treatment options for unresectable stage III NSCLC include definitive RT, chemotherapy, combined chemoradiotherapy, or supportive care. Compared with radiation alone or chemotherapy alone, the combination of chemotherapy and standard RT confers a modest survival benefit at the cost of increased toxicity for patients with an excellent performance status. For metastatic disease, combination chemotherapy--in particular, platinum-based regimens--improves symptom control and survival. Newer chemotherapeutic agents with higher response rates and favorable toxicity profiles are improving outcome even for the elderly and debilitated patients and those refractory to first-line chemotherapy. Evolving understanding of the molecular events in tumorigenesis is uncovering a host of promising targets for mechanism-based therapy. Many of these novel target modulators likely will require combination with conventional chemotherapy for optimal results.

References

Feb 20, 1992·The New England Journal of Medicine·C Schaake-KoningA Nijs
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·J F Fowler, M J Lindstrom
Jun 1, 1991·International Journal of Radiation Oncology, Biology, Physics·R J CoffeyL D Lunsford
Oct 1, 1991·International Journal of Radiation Oncology, Biology, Physics·A HerskovicJ Holt
Nov 1, 1990·International Journal of Radiation Oncology, Biology, Physics·M I Saunders, S Dische
Feb 22, 1990·The New England Journal of Medicine·R A PatchellB Young
Apr 1, 1985·International Journal of Radiation Oncology, Biology, Physics·J R SimpsonD V Rao
Mar 14, 1985·The New England Journal of Medicine·P J O'DwyerR E Wittes
May 1, 1986·The British Journal of Radiology·M I Saunders, S Dische
Oct 1, 1985·American Journal of Clinical Oncology·R KomakiN Rangala
Apr 10, 1971·Lancet·K R DurrantW S Hamilton
Jan 1, 1980·International Journal of Radiation Oncology, Biology, Physics·B BorgeltF R Hendrickson
Jan 1, 1980·International Journal of Radiation Oncology, Biology, Physics·J D CoxM Greenberg
Aug 1, 1980·International Journal of Radiation Oncology, Biology, Physics·L R Holsti, K Mattson
Dec 1, 1995·International Journal of Radiation Oncology, Biology, Physics·G S SibleyS Vijayakumar
Dec 1, 1995·International Journal of Radiation Oncology, Biology, Physics·M V GrahamW B Harms
Jan 4, 1995·Journal of the National Cancer Institute·E AlexanderJ S Loeffler
Mar 3, 1993·Journal of the National Cancer Institute·W K MurphyM N Raber
Mar 1, 1994·International Journal of Radiation Oncology, Biology, Physics·J C FlickingerP K Sneed
Jan 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V AlberolaJ M Pérez

❮ Previous
Next ❯

Citations

Apr 20, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Charles H WeissmanLina Asmar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.